comparemela.com

Latest Breaking News On - Arkinson 39s disease - Page 12 : comparemela.com

Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson s disease

Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson's disease (PD).

Chinnapong shutterstockNational institutes of healthNature communicationsNational institutesCellular thermal shift assayAdeno associated virusTyrosine hydroxylaseArkinson 39s disease

Associations between screen time, exercise habits, and the onset of dementia, Parkinson s disease, and depression

Researchers explore the prospective link between screen time and the risk of developing dementia, Parkinson's disease, and depression.

United kingdomDrobot shutterstockSiemens skyraInternational physical activity questionnaireInternational classification of diseasesInternational journal of behavioral nutritionalInternational journalBehavioral nutritionalPhysical activityDean drobotUnited kingdom biobankInternational classificationTenth revisionArkinson 39s diseaseNeurodegenerative diseasesPhysical activity

Neural circuit linked to aversion and depression discovered

Researchers have identified a new neural circuit in the brain which produces a strong sense of discomfort when activated.

Uppsala lanLily ramseyBordeaux universitySwedish research councilUppsala universityParkinson foundationMichaelj fox foundationSwedish brain foundationResearch foundationDepartment of organismal biology at uppsala universityOrganismal biologyAligning science across parkinsonWenner gren foundationsSwedish researchArkinson 39s disease

Game-changer for Parkinson s therapy: Innovative neuroprosthesis enhances mobility and balance

Researchers designed a neuroprosthesis replicating the natural lumbosacral spinal activation during walking for Parkinson's disease (PD) patients.

Nature medicineBrain stimulationDeep brain stimulationMotor neuronsArkinson 39s disease

US Neurologists Emphasize Tremendous Unmet Treatment Need

Gene therapies and LRRK2 inhibition are at the forefront of prescribers interest, highlighting the need for a truly disease modifying therapy..

United statesAnnovis bioAddex pharmaSpherix networkSpherix global insight market dynamixDenali therapeuticCerevel therapeuticSun pharma advanceGlobal insightsSpherix global insightsSpherix global insightArkinson 39s diseaseEnali theraputicsSun pharmaAnnovis bioAddex pharma

vimarsana © 2020. All Rights Reserved.